U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 1

Figure 1. From: Case Report: Metabolic Profiling Identifies Lung Tumor Responsiveness to Erlotinib.

PET images of upper and lower lobe lung lesions (indicated by arrows) of an 80-year old Asian female patient. Red to white colors indicates high to low density.

Teresa W-M Fan, et al. Exp Mol Pathol. ;87(1):83-86.
2.
Figure 3

Figure 3. From: Case Report: Metabolic Profiling Identifies Lung Tumor Responsiveness to Erlotinib.

Metabolite concentration in normal, upper and lower lobe lung nodules.
Myo-inositol (Ino), glucose (Glc), phosphocholine (PCh) were quantified from 1H NMR spectra in while the other metabolites were quantified by GC-MS as described previously (). Lac: lactate; α-G3P: α-glycerol-3-phosphate; Suc: succinate; Fum: fumarate; Cit: citrate. UL upper lobe, LL lower lobe

Teresa W-M Fan, et al. Exp Mol Pathol. ;87(1):83-86.
3.
Figure 2

Figure 2. From: Case Report: Metabolic Profiling Identifies Lung Tumor Responsiveness to Erlotinib.

1H NMR spectra of extracts of paired normal and lung lesions.
Flash frozen slices from upper lobe (UL, top panel), lower lobe (LL, middle panel) nodules, and non-cancerous tissues (bottom panel) were taken from the resected lung of the patient shown in , and extracted with 10% TCA and 1H NMR spectra of extracts were recorded at 600 MHz. Metabolite assignments were based on our in-house database, 2-D 1H TOCSY and 1H-13C HSQC NMR spectra (not shown) (). The three spectra were normalized in terms of tissue weight and NMR spectral parameters for direct comparison.

Teresa W-M Fan, et al. Exp Mol Pathol. ;87(1):83-86.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center